Your browser doesn't support javascript.
loading
Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey.
Denburg, Avram E; Fundytus, Adam; Khan, Muhammad Saghir; Howard, Scott C; Antillon-Klussmann, Federico; Sengar, Manju; Lombe, Dorothy; Hopman, Wilma; Jalink, Matthew; Gyawali, Bishal; Trapani, Dario; Roitberg, Felipe; De Vries, Elisabeth G E; Moja, Lorenzo; Ilbawi, André; Sullivan, Richard; Booth, Christopher M.
Afiliação
  • Denburg AE; Division of Haematology/Oncology, Department of Paediatrics, University of Toronto, Toronto, Canada.
  • Fundytus A; Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Khan MS; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.
  • Howard SC; Department of Paediatrics, King Faisal Specialist Hospital and Research Center, Al Madinah Al Munawarrah, Saudi Arabia.
  • Antillon-Klussmann F; University of Tennessee Health Science Center, Memphis, TN.
  • Sengar M; School of Medicine, Francisco Marroquin University, Guatemala, Guatemala.
  • Lombe D; Unidad Nacional de Oncologia Paediatrica, Guatemala, Guatemala.
  • Hopman W; Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.
  • Jalink M; Department of Radiation Oncology, MidCentral District Health Board, Palmerston North, New Zealand.
  • Gyawali B; Department of Public Health Sciences, Queen's University, Kingston, Canada.
  • Trapani D; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.
  • Roitberg F; Department of Public Health Sciences, Queen's University, Kingston, Canada.
  • De Vries EGE; Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Canada.
  • Moja L; Department of Public Health Sciences, Queen's University, Kingston, Canada.
  • Ilbawi A; Department of Oncology, Queen's University, Kingston, Canada.
  • Sullivan R; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.
  • Booth CM; Department of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland.
JCO Glob Oncol ; 8: e2200034, 2022 06.
Article em En | MEDLINE | ID: mdl-35749676
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article